JAMA Cardiology

Cardiology

Direct oral anticoagulants plus antiplatelets effective in ACS

(HealthDay)—For patients with acute coronary syndrome (ACS), treatment with direct oral anticoagulants (DOACs) in addition to antiplatelet therapy (APT) appears efficacious for those with ST-segment elevation myocardial ...

Cardiology

Depression ups mortality risk post aortic valve replacement

(HealthDay)—The presence of depressive symptoms among older adults undergoing transcatheter (TAVR) or surgical (SAVR) aortic valve replacement increases the risk of mortality, according to research published online Jan. ...

Cardiology

Omega-3 fatty acids not found to up risk of heart disease

(HealthDay)—Supplementation with omega-3 fatty acids is not associated with fatal or nonfatal coronary heart disease or major vascular events, according to a review published online Jan. 31 in JAMA Cardiology.

Cardiology

High-risk plaque on coronary CTA linked to future MACE

(HealthDay)—For outpatients with stable chest pain, high-risk plaque found by coronary computed tomographic angiography (CTA) is associated with subsequent major adverse cardiovascular events (MACE), according to a study ...

Cardiology

Incomplete revascularization in PCI linked to higher mortality

(HealthDay)—The risk of mortality is increased for certain patients undergoing percutaneous coronary intervention (PCI) with incomplete revascularization (IR), according to a study published online Dec. 27 in JAMA Cardiology.

Cardiology

Serial hsTnT level IDs risk of 30-day adverse cardiac event

(HealthDay)—High-sensitivity troponin (hsTnT) assay can identify patients presenting with suspected acute coronary syndrome at very low risk for 30-day adverse cardiac events (ACE), according to a study published online ...

page 24 from 32